Becton Dickinson
 |
|
| Public | |
| Traded as | : BDX S&P 500 Component |
| Industry | Medical equipment |
| Founded | East Rutherford, New Jersey (1897) |
| Founder | Maxwell Becton and Fairleigh S. Dickinson |
| Headquarters |
BD Headquarters Franklin Lakes, New Jersey, U.S. |
|
Area served
|
Worldwide |
|
Key people
|
Vincent Forlenza (Chairman, CEO and President) |
| Revenue |
 US$10.28 billion (FY 2015)
|
|
US$1.07 billion (FY 2015)
|
|
|
US$695 million (FY 2015)
|
|
| Total assets |
 US$26.8 billion (FY 2015)
|
| Total equity |
US$7.16 billion (FY 2015)
|
|
Number of employees
|
49,500 (September 2015)
|
| Divisions | BD Medical; BD Life Sciences |
| Website | bd |
Vincent Forlenza (Chairman, CEO and President)
Chris Reidy (Acting Chief Financial Officer, Senior Vice President and Controller)
Coordinates: 41°00′57″N 74°12′36″W / 41.015834°N 74.210136°W
Becton, Dickinson and Company (BD) is an American medical technology company that manufactures and sells medical devices, instrument systems and reagents. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 50,000 people in more than 50 countries throughout the world. In fiscal year ending September 30, 2009, 60% of BD sales were generated from non-U.S. markets.
The company's customers include healthcare institutions, science researchers, clinical laboratories, the pharmaceutical industry, and the general public. BD was one of the first companies to sell U.S.-made glass syringes. It was also a pioneer in the production of hypodermic needles. Today, BD is divided into three segments: BD Medical, BD Diagnostics and BD Biosciences. BD is ranked #336 in the 2014 Fortune 500 list.
...
Wikipedia